Health

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Sports Desk: Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek US authorization for this age group soon — a key step

ReadMore

Researchers Studying Cambodia bats to track origin of Covid-19

Shawdesh Desk: Researchers are collecting samples from bats in northern Cambodia in a bid to understand the coronavirus pandemic, returning to a region where a very similar virus was found

ReadMore

‘Ebola is defeated’, says Congolese professor who discovered virus

Shawdesh Desk: Ebola has been defeated. Vaccines and medical treatments have brought the deadly and terrifying disease under control, says Jean-Jacques Muyembe, the Congolese professor who first discovered the virus

ReadMore

6 months’ immunity in mild Covid patients as antibodies persist: Study

Shawdesh Desk: A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. The findings

ReadMore

Covid: Vaccine protection still strong – Oxford jab creator

Shawdesh Desk: The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine. The UK’s vaccine advisory body

ReadMore

Is there a link between post-Covid recovery and heart attacks?

Shawdesh Desk: These aren’t the only instances of people having encountered heart attacks post-COVID. An Oxford-led study conducted recently established that over 50%, or 5 out of every 10 COVID-19

ReadMore

COVID vaccine creator says mass boosters may be unnecessary

Shawdesh Desk: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor

ReadMore

EU and AstraZeneca reach deal to end vaccine row

Shawdesh Desk: The EU and UK-Swedish drug-maker AstraZeneca have settled a row over a shortfall in coronavirus vaccines that affected the European rollout earlier this year. AstraZeneca has agreed to

ReadMore